Ming-liang Cheng

565 total citations
22 papers, 386 citations indexed

About

Ming-liang Cheng is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming-liang Cheng has authored 22 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming-liang Cheng's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (3 papers) and Gut microbiota and health (3 papers). Ming-liang Cheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (3 papers) and Gut microbiota and health (3 papers). Ming-liang Cheng collaborates with scholars based in China and United States. Ming-liang Cheng's co-authors include Zhuo Cheng, Xueke Zhao, Lei Yu, Yaxin Hu, Yongmei Liu, Lei Yu, Mao Mu, Chi Chen, Shuo Cong and Yongmei Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Ming-liang Cheng

21 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-liang Cheng China 10 173 100 57 41 35 22 386
Yaxin Hu China 12 177 1.0× 87 0.9× 51 0.9× 26 0.6× 29 0.8× 20 384
Kadakkal Radhakrishnan United States 12 81 0.5× 119 1.2× 103 1.8× 53 1.3× 19 0.5× 39 491
Hongyang Liu China 14 189 1.1× 87 0.9× 95 1.7× 32 0.8× 28 0.8× 37 528
Mirjam H. Koster Netherlands 9 283 1.6× 94 0.9× 50 0.9× 13 0.3× 21 0.6× 21 515
J K Limdi United Kingdom 4 90 0.5× 159 1.6× 84 1.5× 48 1.2× 21 0.6× 13 496
Seong‐Hwan Chang South Korea 17 161 0.9× 105 1.1× 101 1.8× 24 0.6× 45 1.3× 57 702
Daniel Contaifer United States 13 181 1.0× 336 3.4× 88 1.5× 23 0.6× 29 0.8× 22 700
Qingqiang Ni China 12 216 1.2× 67 0.7× 41 0.7× 24 0.6× 22 0.6× 29 498
Waqar Khalid Saeed South Korea 13 190 1.1× 300 3.0× 120 2.1× 23 0.6× 52 1.5× 26 554
Yingjie Guo China 8 173 1.0× 44 0.4× 47 0.8× 41 1.0× 52 1.5× 22 399

Countries citing papers authored by Ming-liang Cheng

Since Specialization
Citations

This map shows the geographic impact of Ming-liang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-liang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-liang Cheng more than expected).

Fields of papers citing papers by Ming-liang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-liang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-liang Cheng. The network helps show where Ming-liang Cheng may publish in the future.

Co-authorship network of co-authors of Ming-liang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-liang Cheng. A scholar is included among the top collaborators of Ming-liang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-liang Cheng. Ming-liang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ming-liang, et al.. (2023). Prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis. Scientific Reports. 13(1). 283–283. 1 indexed citations
2.
Liu, Yang, et al.. (2022). Protective effect of endothelial progenitor cell-derived exosomal microRNA-382-3p on sepsis-induced organ damage and immune suppression in mice.. PubMed. 14(10). 6856–6873. 11 indexed citations
3.
Cheng, Ming-liang, et al.. (2021). Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER. Scientific Reports. 11(1). 14790–14790. 2 indexed citations
4.
Liu, Yongmei, Zhuo Cheng, Lei Yu, et al.. (2021). Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance. Scientific Reports. 11(1). 1611–1611. 37 indexed citations
5.
Cheng, Ming-liang, et al.. (2020). [Probiotics enhance the efficacy of fecal microbiota transplantation in severe acute liver injury].. PubMed. 28(4). 345–350. 1 indexed citations
6.
Liu, Yongmei, Shuo Cong, Zhuo Cheng, et al.. (2020). Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway. European Journal of Pharmacology. 876. 172946–172946. 53 indexed citations
8.
Hu, Yaxin, Xinyan Liu, Zhuo Cheng, et al.. (2018). The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. PLoS ONE. 13(8). e0201136–e0201136. 32 indexed citations
9.
Liu, Yongmei, et al.. (2018). AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study. Lipids in Health and Disease. 17(1). 275–275. 80 indexed citations
10.
Yu, Lei, Xueke Zhao, Ming-liang Cheng, et al.. (2017). Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Scientific Reports. 7(1). 1359–1359. 62 indexed citations
11.
Cheng, Yiju, Ruiyang Wu, Ming-liang Cheng, et al.. (2016). Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions. Oncotarget. 8(19). 32228–32236. 23 indexed citations
13.
Peng, Hong & Ming-liang Cheng. (2008). [The relationship of metallothionein and liver fibrosis].. PubMed. 16(1). 78–9. 4 indexed citations
14.
Cheng, Ming-liang, et al.. (2008). Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis.. PubMed. 7(2). 179–84. 11 indexed citations
15.
Shan, Ke-ren, Yunshu Zhou, Yang Qin, et al.. (2007). [Research into methylation of p16 gene in the patients suffering from coal-burnt arsenism in Xingren County Guizhou Province].. PubMed. 41(1). 29–32. 1 indexed citations
16.
Yang, Qin, et al.. (2007). [Differential analysis of associated proteome in hepatic fibrosis tissue].. PubMed. 87(48). 3411–4. 2 indexed citations
17.
Yang, Qin, et al.. (2005). [Expression of PKC in rat hepatic fibrosis and the effect of Dan-shao-hua-xian Capsule on its expression pattern].. PubMed. 13(9). 707–8. 6 indexed citations
18.
Cheng, Ming-liang. (2002). Effect of Maotai liquor in inducing metallothioneins and on hepatic stellate cells. World Journal of Gastroenterology. 8(3). 520–520. 12 indexed citations
19.
Lü, Tong, et al.. (2000). [Changes of collagenase activity in immune hepatic fibrosis following pig's serum injection and therapeutic effect of HanDanGanLe].. PubMed. 8(2). 108–9. 2 indexed citations
20.
Cheng, Ming-liang, et al.. (1988). Effect of total-body irradiation with bone marrow transplantation on toxicity of cisplatin.. PubMed. 29–33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026